BMO Capital Markets Cuts Phreesia (NYSE:PHR) Price Target to $14.00

Phreesia (NYSE:PHR) had its target price decreased by investment analysts at BMO Capital Markets from $32.00 to $14.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. BMO Capital Markets’ target price would suggest a potential upside of 22.44% from the stock’s current price.

A number of other research firms have also recently commented on PHR. DA Davidson decreased their price target on Phreesia from $35.00 to $30.00 and set a “buy” rating for the company in a research note on Friday, January 23rd. Canaccord Genuity Group cut their price objective on shares of Phreesia from $33.00 to $22.00 and set a “buy” rating on the stock in a report on Tuesday. Barclays decreased their price objective on shares of Phreesia from $26.00 to $24.00 and set an “overweight” rating for the company in a research report on Tuesday, December 16th. Robert W. Baird reiterated a “neutral” rating and issued a $10.00 target price (down from $25.00) on shares of Phreesia in a research note on Tuesday. Finally, Royal Bank Of Canada began coverage on shares of Phreesia in a research note on Friday, January 9th. They set a “moderate buy” rating and a $26.00 price target on the stock. Thirteen analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.71.

Phreesia Price Performance

NYSE PHR opened at $11.43 on Tuesday. The firm’s fifty day simple moving average is $12.51 and its two-hundred day simple moving average is $17.68. The firm has a market capitalization of $689.36 million, a P/E ratio of -114.33 and a beta of 0.67. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.01. Phreesia has a 12-month low of $10.75 and a 12-month high of $32.76.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, March 30th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.05). The business had revenue of $127.07 million for the quarter, compared to analysts’ expectations of $126.75 million. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The business’s revenue for the quarter was up 15.9% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.11) EPS. Analysts forecast that Phreesia will post -1.1 EPS for the current fiscal year.

Insider Buying and Selling at Phreesia

In other Phreesia news, CFO Balaji Gandhi sold 8,009 shares of Phreesia stock in a transaction that occurred on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total transaction of $136,233.09. Following the completion of the sale, the chief financial officer directly owned 156,231 shares in the company, valued at approximately $2,657,489.31. The trade was a 4.88% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, General Counsel Allison C. Hoffman sold 6,585 shares of the company’s stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total transaction of $112,010.85. Following the completion of the sale, the general counsel directly owned 174,762 shares in the company, valued at $2,972,701.62. This trade represents a 3.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 70,358 shares of company stock valued at $1,123,569. 5.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Phreesia

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Raymond James Financial Inc. raised its stake in shares of Phreesia by 2.7% during the 2nd quarter. Raymond James Financial Inc. now owns 14,049 shares of the company’s stock valued at $400,000 after buying an additional 375 shares during the last quarter. Diversified Trust Co boosted its stake in shares of Phreesia by 1.7% in the third quarter. Diversified Trust Co now owns 45,822 shares of the company’s stock worth $1,078,000 after buying an additional 780 shares during the last quarter. Alliancebernstein L.P. boosted its stake in shares of Phreesia by 1.3% in the third quarter. Alliancebernstein L.P. now owns 62,712 shares of the company’s stock worth $1,475,000 after buying an additional 812 shares during the last quarter. Van ECK Associates Corp grew its holdings in Phreesia by 78.7% during the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after acquiring an additional 1,102 shares during the period. Finally, Arizona State Retirement System grew its holdings in Phreesia by 8.1% during the third quarter. Arizona State Retirement System now owns 17,608 shares of the company’s stock worth $414,000 after acquiring an additional 1,313 shares during the period. 92.10% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Phreesia

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Company reported positive GAAP net income and strong free cash flow for the fiscal year — exceeded internal targets including crossing $100M of Adjusted EBITDA and roughly $50M+ of free cash flow, a proof point for profitability and capital-generation that can support valuation. Phreesia Announces Fourth Quarter Fiscal 2026 Results
• Positive Sentiment: Management highlighted record revenue growth and strategic initiatives on the Q4 call, indicating underlying demand and execution on product/partnership priorities that investors view as longer-term upside. Phreesia Inc (PHR) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic …
• Neutral Sentiment: Full earnings-call transcript is available for detail seekers — useful for investors who want management’s color on drivers, margin improvement, and the AccessOne integration timeline. Phreesia, Inc. (PHR) Q4 2026 Earnings Call Transcript
• Neutral Sentiment: Several analysts revised expectations heading into the print, lowering EPS/forecast assumptions — shows sentiment was already shifting and likely amplified intraday moves. Top Wall Street Forecasters Revamp Phreesia Expectations Ahead Of Q4 Earnings
• Negative Sentiment: Management cut near-term outlook: FY2027 revenue was guided to $510M–$520M and executives warned of headwinds from the network solutions business and integration-related pressure from AccessOne — a driver of the recent sell-off. Phreesia outlines $510M–$520M revenue target for 2027 amid network solutions headwinds and AccessOne integration
• Negative Sentiment: Market reaction: shares plunged after the EPS miss and guidance cut (reports of a ~22% drop and all-time lows in some sessions) — short-term momentum and sentiment risk remain. Phreesia shares tumble 22% on earnings miss, slashed guidance

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.